top of page

Right-sizing, not downsizing, for post-covid

  • Writer: Laurent DECORY
    Laurent DECORY
  • Dec 12, 2020
  • 1 min read

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies.

For post-covid commercial restart, life science companies need to prepare for right sizing, not downsizing.

It could mean different setup, new capabilities, or move to omni-channel.

BlueJet Consulting can help !






Continue reading

Comments


bottom of page